Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Hynes

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
The Journal of the Kansas Medical Society|January 1, 1984
Carcinomatous meningitisR S Smith, J B Zatzkin, H E Hynes
Southern Medical Journal|May 1, 1983
Ovarian carcinoma metastatic to breastJ D Hughes, H E Hynes, J J Lin
Investigational New Drugs|December 1, 1987
Phase II evaluation of aclacinomycin-A in advanced ovarian carcinomaS Martino, D A Decker, H E Hynes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapyD F Housholder, H E Hynes, S R Dakhil, et al.
Cancer Treatment Reports|July 1, 1982
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group StudyC J Fabian, L H Baker, C B Vaughn, et al.
Investigational New Drugs|November 1, 1991
Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group studyJ P Kuebler, B Metch, D E Schuller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Anticipatory nausea and vomiting in the era of 5-HT3 antiemeticsG R Morrow, J A Roscoe, J J Kirshner, et al.
Kansas Medicine : the Journal of the Kansas Medical Society|July 1, 1986
An implantable drug delivery systemR L Ernst, F C Chang, H E Hynes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 1998
Progress in reducing anticipatory nausea and vomiting: a study of community practiceG R Morrow, J A Roscoe, H E Hynes, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
The Journal of the Kansas Medical Society|January 1, 1984
Carcinomatous meningitisR S Smith, J B Zatzkin, H E Hynes
Southern Medical Journal|May 1, 1983
Ovarian carcinoma metastatic to breastJ D Hughes, H E Hynes, J J Lin
Investigational New Drugs|December 1, 1987
Phase II evaluation of aclacinomycin-A in advanced ovarian carcinomaS Martino, D A Decker, H E Hynes, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 1, 1985
Hepatobiliary scintigraphy in patients receiving hepatic artery infusion chemotherapyD F Housholder, H E Hynes, S R Dakhil, et al.
Cancer Treatment Reports|July 1, 1982
Phase II evaluation of gallium nitrate in breast cancer: a Southwest Oncology Group StudyC J Fabian, L H Baker, C B Vaughn, et al.
Investigational New Drugs|November 1, 1991
Phase II study of fazarabine in advanced head and neck cancer. A Southwest Oncology Group studyJ P Kuebler, B Metch, D E Schuller, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 18, 1998
Anticipatory nausea and vomiting in the era of 5-HT3 antiemeticsG R Morrow, J A Roscoe, J J Kirshner, et al.
Kansas Medicine : the Journal of the Kansas Medical Society|July 1, 1986
An implantable drug delivery systemR L Ernst, F C Chang, H E Hynes, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 1998
Progress in reducing anticipatory nausea and vomiting: a study of community practiceG R Morrow, J A Roscoe, H E Hynes, et al.
Investigational New Drugs|January 1, 1994
Phase II evaluation of mitoxantrone plus cis-platinum in patients with advanced breast cancer. A Southwest Oncology Group studyJ O Atiba, S J Green, H E Hynes, et al.
Pageof 4